# Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

> **NCT06396845** · — · COMPLETED · sponsor: **Daorong Wang** · enrollment: 505 (actual)

## Conditions studied

- Robotic
- Laparoscopic
- Anterior Resection for Rectal Cancer

## Interventions

- **PROCEDURE:** robotic surgery
- **PROCEDURE:** laparoscopic surgery

## Key facts

- **NCT ID:** NCT06396845
- **Lead sponsor:** Daorong Wang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2024-01-03
- **Target enrollment:** 505 (ACTUAL)
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06396845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06396845, "Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06396845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*